News | March 16, 2026
Zuellig Pharma expands Cialis footprint across Asia
The expanded ownership is expected to improve access to Cialis for millions of men in Asia affected by ED and BPH
The expanded ownership is expected to improve access to Cialis for millions of men in Asia affected by ED and BPH
Achondroplasia, a rare genetic disorder, causes skeletal dysplasia and often increases the risk of muscular, neurological, and cardiorespiratory complications
The collaboration will leverage Medi Assist’s proprietary technology to streamline claims processing, enhance transparency, and deliver smarter health benefits to policyholders in the region
40+ most innovative startups with disruptive contributions across MedTech, Medical Devices, BioPharma, Cell and Gene Therapy, AI and ML, Nutraceuticals, and Biomarkers exhibited their cutting-edge solutions
Achondroplasia is a genetic condition driven by FGFR3 that affects more than stature alone
BioAsia 2026 represents a decisive shift toward execution, scale, and global competitiveness, reflecting the rapid evolution of the life sciences ecosystem
This recognition demonstrate excellence in intellectual property (IP) value creation.
The FDA has classified recent submissions as a major amendment pushing the approval to its NDA for TransCon CNP back three months to February 28, 2026
The Eurasian Patent Organization (EAPO) has granted Patent, protecting the company’s sublingual delivery technology for anticancer drugs used to treat autoimmune and neurodegenerative diseases
The licence covers Actimed’s existing patents, its proprietary know-how and any future related patents, giving Mankind full control to advance the products under its own brands
Subscribe To Our Newsletter & Stay Updated
